Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, today announces that it will present data on its most promising candidate at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona, Spain, on November 18-21, 2014. Genoscience Pharma has developed a unique therapeutic approach that simultaneously eliminates differentiated cancerous cells whilst also eradicating the stem cells that generated the cancerous cells in the first place.
http://ift.tt/1uist3L
http://ift.tt/1uist3L
No comments:
Post a Comment